Home > Boards > US Listed > Biotechs > Organovo Holdings, Inc. (ONVO)

$ONVO An Open Letter to Organovo Shareholders: Organovo

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
MWM Member Profile
Member Level 
Followed By 1,016
Posts 137,039
Boards Moderated 16
Alias Born 03/31/06
160x600 placeholder
Annual Report (10-k) Edgar (US Regulatory) - 6/15/2021 4:07:38 PM
Organovo up 36% on bullish assessment of 3D human tissue biotech Seeking Alpha - 5/28/2021 12:11:23 PM
Aesthetic Medical International, Acorda Therapeutics leads healthcare gainers; Atea Pharmaceuticals, Inotiv among major losers Seeking Alpha - 4/21/2021 11:01:52 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 3/25/2021 7:32:52 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/10/2021 4:49:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/10/2021 4:47:53 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/10/2021 4:47:04 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 3/10/2021 3:11:33 PM
Organovo Announces Participation at the H.C. Wainwright Global Life Sciences Conference March 9-10 2021 (VIRTUAL CONFERENCE) GlobeNewswire Inc. - 3/2/2021 8:05:00 AM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 4:46:09 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/8/2021 4:06:55 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/5/2021 6:12:48 AM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 1/19/2021 5:02:25 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/25/2020 5:26:34 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/5/2020 4:13:09 PM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/21/2020 8:05:48 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2020 7:28:26 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2020 7:26:20 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2020 7:24:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2020 7:20:25 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2020 7:18:28 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 9/17/2020 7:16:47 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/17/2020 7:07:15 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/17/2020 7:05:34 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/17/2020 7:03:28 PM
MWM Member Level  Wednesday, 01/06/21 01:04:23 PM
Re: None
Post # of 10431 
$ONVO An Open Letter to Organovo Shareholders: Organovo Founder Sees Continued Success in Bioprinting

Keith Murphy, founder, former CEO and Chairman Emeritus of Organovo, says bioprinting and similar technologies are going strong and still growing
Companies in the space are finding support from institutional capital sources, and those with tools and service business models are achieving 40%+ per year revenue growth
Viscient Biosciences, Mr. Murphy’s current company, has already crossed a major milestone in the application of bioprinting to NASH drug discovery
Viscient incorporates into bioprinting additional cutting edge techniques, including single cell sequencing and bioinformatics tools
Major investment funds have expressed support for Viscient’s approach
January 07, 2020 08:00 AM Eastern Standard Time

https://www.businesswire.com/news/home/20200107005367/en/Open-Letter-Organovo-Shareholders-Organovo-Founder-Sees

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences